Case Report: Post-Liver Transplant Crohn's Disease Refractory to Anti-tumor Necrosis Factor Agents

被引：0
|
作者：
Yilmaz, Yusufcan [1 ]
Keskin, Onur [1 ]
Toruner, Murat [2 ]
机构：
[1] Ankara Univ, Ankara, Turkey
[2] Ankara Univ, Sch Med, Ankara, Turkey
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-02924
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2923
引用
收藏
页码：S1561 / S1561
页数：1
相关论文
共 50 条
  • [21] Effectiveness and Safety of lmmunomodulators With Anti-Tumor Necrosis Factor Therapy in Crohn's Disease
    Osterman, Mark T.
    Haynes, Kevin
    Delzell, Elizabeth
    Zhang, Jie
    Bewtra, Meenakshi
    Brensinger, Colleen M.
    Chen, Lang
    Xie, Fenglong
    Curtis, Jeffrey R.
    Lewis, James D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : 1293 - +
  • [22] Optimizing the use of anti-tumor necrosis factor in the management of patients with Crohn's disease
    Nguyen, Douglas L.
    Flores, Sarah
    Sassi, Kareem
    Bechtold, Matthew L.
    Nguyen, Emily T.
    Parekh, Nimisha K.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (03) : 147 - 154
  • [23] Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease
    Suenaert, P
    Bulteel, V
    Lemmens, L
    Noman, M
    Geypens, B
    Van Assche, G
    Geboes, K
    Ceuppens, JL
    Rutgeerts, P
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (08): : 2000 - 2004
  • [24] Use of Vitamin D With Anti-Tumor Necrosis Factor Therapy for Crohn's Disease
    Bafutto, Mauro
    Oliveira, Enio Chaves
    Rezende Filho, Joffre
    GASTROENTEROLOGY RESEARCH, 2020, 13 (03) : 101 - 106
  • [25] Anti-Tumor Necrosis Factor Agents in Inflammatory Eye Disease
    Lowder, Careen
    Choudhary, Maria
    Hajj-ali, Rula
    Srivastava, Sunil
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [26] A cost-efficacy analysis model for physician administered anti-tumor Necrosis factor agents in Crohn's Disease
    Waters, H.
    McKenzie, R.
    Tang, B.
    Piech, C.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S37 - S38
  • [27] The Effect of Anti-Tumor Necrosis Factor Alpha Agents on Postoperative Anastomotic Complications in Crohn's Disease: a Systematic Review
    El-Hussuna, Alaa
    Krag, Aleksander
    Olaison, Gunnar
    Bendtsen, Flemming
    Gluud, Lise L.
    DISEASES OF THE COLON & RECTUM, 2013, 56 (12) : 1423 - 1433
  • [28] A COST-EFFICACY ANALYSIS MODEL FOR PHYSICIAN ADMINISTERED ANTI-TUMOR NECROSIS FACTOR AGENTS IN CROHN'S DISEASE
    Waters, H.
    McKenzie, R. S.
    Tang, B.
    Piech, C. T.
    Papandrikopoulou, N.
    VALUE IN HEALTH, 2008, 11 (06) : A521 - A521
  • [29] Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn's Disease
    Singh, Siddharth
    Heien, Herbert C.
    Sangaralingham, Lindsey R.
    Schilz, Stephanie R.
    Kappelman, Michael D.
    Shah, Nilay D.
    Loftus, Edward V., Jr.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (08) : 1120 - +
  • [30] A cost-efficacy analysis model for physician administered anti-tumor necrosis factor agents in Crohn's disease
    Waters, H.
    McKenzie, R.
    Tang, B.
    Piech, C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S393 - S393
12345